Immune responses of different mouse strains after challenge with equivalent lethal doses of toxoplasma gondii

Parasite

Volumn 11, Issue 1, 2004, Pages 89-97

  Lee, Y H ^a   Kasper, L H ^b  

^a Chungnam National University   (South Korea)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Immune response; Lethal equivalence; Mouse; Susceptibility; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE; TOXOPLASMA GONDII;

ANIMALIA; TOXOPLASMA GONDII;

EID: 1642271303     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/200411189     Document Type: Article

References (24)

1. + T cells determine cyst number in Toxoplasma gondii infection. Journal of Immunology, 1990, 145, 3438-3441.
2. BURG J.L., GROVER C.M., POULETTY P. & BOOTHROYD J.C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. Journal of Clinical Microbiology, 1989, 27, 1787-1792.
3. CANDOLFI E., HUNTER C.A. & REMINGTON J.S. Mitogen-and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infection and Immunity, 1994, 62, 1995-2001.
4. CANDOLFI E., HUNTER C.A. & REMINGTON J.S. Roles of gamma-interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and Toxoplasma antigen during acute toxoplasmosis. Infection and Immunity, 1995, 63, 751-756.
5. DECKERT-SCHLUTER M., ALBRECHT S., HOF H., WIESTLER O.D. & SCHLUTER D. Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice. Immunology, 1995, 85, 408-18.
6. DENKERS E.Y. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes and Infection, 1999, 1, 699-708.
7. HAQUE S., HAQUE A. & KASPER L.H. A Toxoplasma gondii-derived factor(s) stimulates immune downregulation: an in vitro model. Infection and Immunity, 1995, 63, 3442-3447.
8. HUNTER C.A., LITTON M.J., REMINGTON J.S. & ABRAMS J.S. Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. Journal of Infectious Diseases, 1994, 170, 939-945.
9. JOHNSON J., SUZUKI Y., MACK D., MUI E., ESTES R., DAVID C., SKAMENE E., FORMAN J. & MCLEOD R. Genetic analysis of influences on survival following Toxoplasma gondii infection. International Journal for Parasitology, 2002, 32, 179-185.
10. KASPER L.H., MATSUURA T., FONSEKA S., ARRUDA J., CHANNON J.Y. & KHAN I.A. Induction of γδ T cells during acute murine infection with Toxoplasma gondii. Journal of Immunology, 1996, 157, 5521-5527.
11. + T cell clone protects against acute Toxoplasma gondii infection in mice. Journal of Immunology 1994, 152, 1856-1860.
12. KHAN I.A., MATSUURA T. & KASPER L.H. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunology 1995, 17, 185-195.
13. KHAN I.A., MATSUURA T. & KASPER L.H. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. Journal of Immunology, 1998, 161, 2994-3000.
14. LEE Y.H., CHANNON J.Y., MATSUURA T., SCHWARTZMAN J.D., SHIN D.W. & KASPER L.H. Functional and quantitative analysis of splenic T cell immune responses following oral Toxoplasma gondii infection in mice. Experimental Parasitology, 1999a, 91, 212-221.
15. LEE Y.H., ELY K.H., LEPAGE A. & KASPER L.H. Interleukin-15 enhances host protection against acute Toxoplasma gondii infection in T-cell receptor α-/-deficient mice. Parasite Immunology, 1999b, 21, 299-306.
16. LOU W., AOSAI F., UEDA M., YAMASHITA K., SHIMIZU K., SEKIYA S. & YANO A. Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR. Journal of Parasitology, 1997, 83, 1070-1074.
17. MCLEOD R., EISENHAUER P., MACK D., BROWN C., FILICE G. & SPITALNY G. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. Journal of Immunology, 1989, 142, 3247-3255.
18. + T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. Journal of Immunolology, 2002, 168, 2988-2996.
19. MORDUE D.G., MONROY F., LA REGINA M., DINARELLO C.A. & SIBLEY L.D. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. Journal of Immunology, 2001, 167, 4574-4584.
20. NGUYEN T.D., BIGAIGNON G., VAN BROECK J., VERCAMMEN M., NGUYEN T.N., DELMEE M., TURNEER M., WOLF S.F. & COUTELIER J.P. Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses. Infection and Immunity, 1998, 66, 2991-2995.
21. SCHARTON-KERSTEN T.M., WYNN T.A., DENKERS E.Y., BALA S., GRUNVALD E., HIENY S., GAZZINELLI R.T. & SHER A. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. Journal of Immunology, 1996, 157, 4045-4054.
22. SCHLUTER D., DECKERT-SCHLUTER M., LORENZ E., MEYER T., ROLLINGER M. & BOGDAN C. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. Journal of Immunology, 1999, 162, 3512-3518.
23. SUZUKI Y., YANG Q. & REMINGTON J.S. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii. Journal of Parasitology, 1995, 81, 1032-1034.
24. SUZUKI Y., SHER A., YAP G., PARK D., NEYER L.E., LIESENFELD O., FORT M., KANG H. & GUFWOLI E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. Journal of Immunology, 2000, 164, 5375-5382.